Animatus Biosciences
Our Team
Animatus Biosciences
Our Team
Robert Schwartz, Ph.D.
Chief Science Officer
Dr. Robert Schwartz is the Hugh Roy and Lillie Cranz Cullen University Professor in the Department of Biology and Biochemistry at the University of Houston. He is also Director of the Center for Molecular Medicine and Experimental Therapeutics at the University of Houston. Dr. Schwartz earned a B.S. from Brooklyn College and a Ph.D. from the University of Pennsylvania. Previously he was at Baylor College of Medicine as a professor in the Departments of Cell Biology, Molecular and Cellular Biology, Medicine and Molecular Physiology. Dr. Schwartz is considered one of the world’s leading experts in cardiovascular developmental biology.
William Anderson
Chief Operating Officer
Mr. William Anderson is currently CEO of Synthecon, Inc. During Mr. Anderson’s fourteen year tenure as CEO, he has received numerous awards for growth and leadership including three “Fast Tech Fifty” awards given by the Houston Business Journal recognizing Houston’s fastest-growing, high-tech businesses. Additionally, Mr. Anderson has extensive manufacturing experience and has utilized his expertise to apply for and receive numerous patents for cell culture design and manufacturing. Recently, Mr. Anderson applied his industry knowledge on devices to assist in streamlining a “closed loop” cell culture device that Amgen, Inc. uses as their manufacturing solution for its first-in-class oncolytic melanoma vaccine IMLYGIC. Mr. Anderson earned a BS from Sam Houston State University.
Chief Science Officer
Dr. Robert Schwartz is the Hugh Roy and Lillie Cranz Cullen University Professor in the Department of Biology and Biochemistry at the University of Houston. He is also Director of the Center for Molecular Medicine and Experimental Therapeutics at the University of Houston. Dr. Schwartz earned a B.S. from Brooklyn College and a Ph.D. from the University of Pennsylvania. Previously he was at Baylor College of Medicine as a professor in the Departments of Cell Biology, Molecular and Cellular Biology, Medicine and Molecular Physiology. Dr. Schwartz is considered one of the world’s leading experts in cardiovascular developmental biology.
Robert Schwartz, Ph.D.
Chief Operating Officer
Mr. William Anderson is currently CEO of Synthecon, Inc. During Mr. Anderson’s fourteen year tenure as CEO, he has received numerous awards for growth and leadership including three “Fast Tech Fifty” awards given by the Houston Business Journal recognizing Houston’s fastest-growing, high-tech businesses. Additionally, Mr. Anderson has extensive manufacturing experience and has utilized his expertise to apply for and receive numerous patents for cell culture design and manufacturing. Recently, Mr. Anderson applied his industry knowledge on devices to assist in streamlining a “closed loop” cell culture device that Amgen, Inc. uses as their manufacturing solution for its first-in-class oncolytic melanoma vaccine IMLYGIC. Mr. Anderson earned a BS from Sam Houston State University.
